VEGFA was associated with preoperative Apo A level (p < 0.05 between normal and abnormal subgroups); VEGFR1 was associated with preoperative hypertension (p < 0.05); VWF was associated with surgery success (p < 0.05); and TM was associated with preoperative WC (p < 0.05 for abdominal obesity), follow-up duration (p < 0.05 between <1 year and >1 year subgroups), and preoperative hypertension (p < 0.05). Here, VWF is linked to Abdominal obesity.